
289.48 Delayed Data As of Jan 27 | ![]() Today’s Change | 52.33 Today|||52-Week Range 315.45 | -0.27% Year-to-Date |
This "Golden" Technical Indicator is Triggering Across the Market Jan 26 / Zacks.com - Paid Partner Content | Intercept's (ICPT) NDA for NASH Treatment Accepted By FDA Jan 20 / Zacks.com - Paid Partner Content |
Previous close | 300.64 |
Today’s open | 301.52 |
Day’s range | 288.92 - 303.44 |
Volume | 222,274 |
Average volume (3 months) | 502,482 |
Market cap | $5.2B |
Earnings growth (last year) | -11.71% |
Earnings growth (this year) | -14.99% |
Earnings growth (next 5 years) | 0.00% |
Revenue growth (last year) | -- |
P/E ratio | NM |
Price/Sales | -- |
Price/Book | 26.54 |
Next reporting date | March 1, 2023 |
EPS forecast (this quarter) | -$4.62 |
Annual revenue (last year) | $0.00 |
Annual profit (last year) | -$241.8M |
Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters West Conshohocken, Pennsylvania |